CJC-1295

CJC-1295 is a synthetic analogue of GHRH and growth hormone secretagogue (GHS) that has research applications in the fields of growth hormone deficiency, sleep quality, and anti-aging. Inside, researchers will find what they must know about CJC-1295, including results from clinical trials.

SAVE 15%

more 2 products

SAVE 50%

6 for the price of 3

* The information on this page is a summary and is not intended to cover all available information about this medication. It does not cover all possible uses, directions, precautions, drug interactions or adverse effects and is not a substitute for the expertise and judgement of your healthcare professional.

Compound Overview

Class of Compound:

Peptide

Mechanism of Action:

CJC-1295 binds to receptors in the pituitary gland to stimulate the release of plasma growth hormone (GH) and insulin-like growth factor 1 (IGF-1).

Notable Studies:

Also Known As:

UNII-62RC32V9N7, 62RC32V9N7

Research Applications:

Growth hormone deficiency
Body composition
Sleep quality; anti-aging

Risks:

Limited human data
Lack of FDA approval
WADA Prohibited List

Chemical Structure

Customer Reviews

Rated 0 out of 5

0 reviews

Rated 5 out of 5

0

Rated 4 out of 5

0

Rated 3 out of 5

0

Rated 2 out of 5

0

Rated 1 out of 5

0

Reviews

Clear filters

There are no reviews yet.

Be the first to review “CJC-1295”